MiNA Therapeutics raised €25M in a Series A round in Sep 2020. The company is based in London, UK. Investors in the round: aMoon Fund. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
